Dr. Bradley J. Prince, MD, MBA
Medical Genetics and Genomics Specialist
About
Physician-scientist and healthcare leader specializing in Medical Genetics and Genomics at the University of Calgary. Combining medical expertise with business acumen to advance innovative genetic therapies and improve patient care through clinical research and technology implementation.
Education
- Residency: Medical Genetics and Genomics, University of Calgary (2020 - Present)
- MD, MBA: University of Calgary, Leaders in Medicine Program (2014 - 2020)
- BSc: Brigham Young University, Physiological and Developmental Biology (2008-2009, 2011-2014)
Research & Publications
- Co-Investigator: CIHR Operating Grant: CAHN-EDIT-CD3δ - Novel gene therapy for inherited immune deficiency ($2.4M)
- Research Focus: Novel genetic therapies, rare disease genomics, neurodevelopmental disorders, spliceosome genes
- Publications: Author on multiple papers including studies on U4/U5 spliceosome genes, 14q terminal deletion syndrome, ERBB4, AUTS2, and Mennonite founder mutations
Leadership & Innovation
- Founding Director, Business in Leaders in Medicine Seminar Series (BILSS)
- President, Calgary Medical Students Association (2014-2017)
- Co-Founder, eXDee Ltd - Patient reported outcomes platform with dynamic anonymization
- Winner, CMA Joule National Innovation Challenge "3D Printing to Improve Quality of Life"
- Best Oral Presentation, ACHRI Child Health and Wellness Research Retreat (2022)
- First Place, Haskayne MBA Internal Case Competition & IXL Innovation Olympics (Ayala Corp)